AORT Insider Transactions
1,093 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.
AORT insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Mackin James P | President & CEO | 2026-08-19 | Sale | 70,000 | $28.955 |
| GREEN ANDREW M | SVP, Regulatory and Quality | 2026-08-14 | Sale | 616 | $28.549 |
| Berry Lance A | EVP, COO, CFO & Treasurer | 2026-08-14 | Sale | 715 | $28.549 |
| Holloway Jean F | SVP, General Counsel | 2026-08-12 | Sale | 977 | $28.49 |
| GREEN ANDREW M | SVP, Regulatory and Quality | 2026-06-11 | Sale | 30,000.0 | $20.69 |
| GREEN ANDREW M | SVP, Regulatory and Quality | 2026-06-11 | Sale | 14,001.0 | $20.71 |
| Holloway Jean F | SVP, General Counsel | 2026-03-04 | Sale | 8,962.0 | $38.0 |
| Horton Amy | VP, Chief Accounting Officer | 2026-03-03 | Sale | 901.0 | $37.78 |
| Holloway Jean F | SVP, General Counsel | 2026-03-03 | Sale | 3,843.0 | $37.78 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2026-03-03 | Sale | 2,149.0 | $37.78 |
| Davis John E | Chief Commercial Officer | 2026-03-03 | Sale | 4,573.0 | $37.78 |
| Berry Lance A | EVP, COO, CFO & Treasurer | 2026-03-03 | Sale | 6,316.0 | $37.78 |
| Mackin James P | President & CEO | 2026-03-03 | Sale | 17,887.0 | $37.78 |
| Horton Amy | VP, Chief Accounting Officer | 2026-03-02 | Sale | 641.0 | $38.02 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2026-03-02 | Sale | 1,513.0 | $38.02 |
| Mackin James P | President & CEO | 2026-03-02 | Sale | 14,911.0 | $38.02 |
| Holloway Jean F | SVP, General Counsel | 2026-03-02 | Sale | 2,183.0 | $38.02 |
| Berry Lance A | EVP, COO, CFO & Treasurer | 2026-03-02 | Sale | 5,178.0 | $38.02 |
| Davis John E | Chief Commercial Officer | 2026-03-02 | Sale | 2,784.0 | $38.02 |
| Horton Amy | VP, Chief Accounting Officer | 2026-02-24 | Sale | 830.0 | $35.69 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2026-02-24 | Sale | 1,259.0 | $35.69 |
| Holloway Jean F | SVP, General Counsel | 2026-02-24 | Sale | 1,668.0 | $35.69 |
| Mackin James P | President & CEO | 2026-02-24 | Sale | 13,936.0 | $35.69 |
| Berry Lance A | EVP, COO, CFO & Treasurer | 2026-02-24 | Sale | 4,485.0 | $35.69 |
| Davis John E | Chief Commercial Officer | 2026-02-24 | Sale | 2,075.0 | $35.69 |
| Horton Amy | VP, Chief Accounting Officer | 2026-02-23 | Sale | 1,731.0 | $37.59 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2026-02-23 | Sale | 2,423.0 | $37.59 |
| Holloway Jean F | SVP, General Counsel | 2026-02-23 | Sale | 3,079.0 | $37.59 |
| Mackin James P | President & CEO | 2026-02-23 | Sale | 20,962.0 | $37.59 |
| Berry Lance A | EVP, COO, CFO & Treasurer | 2026-02-23 | Sale | 4,981.0 | $37.59 |
| Davis John E | Chief Commercial Officer | 2026-02-23 | Sale | 3,773.0 | $37.59 |
| Davis John E | Chief Commercial Officer | 2025-12-15 | Sale | 5,000.0 | $45.11 |
| Horton Amy | VP, Chief Accounting Officer | 2025-12-08 | Sale | 4,572.0 | $44.42 |
| Mackin James P | President & CEO | 2025-12-03 | Sale | 30,921.0 | $45.46 |
| Holloway Jean F | SVP, General Counsel | 2025-12-03 | Sale | 5,267.0 | $45.3 |
| Holloway Jean F | SVP, General Counsel | 2025-12-03 | Sale | 2,048.0 | $45.3 |
| Mackin James P | President & CEO | 2025-12-02 | Sale | 30,921.0 | $45.56 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2025-11-21 | Sale | 8,370.0 | $45.35 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2025-11-21 | Sale | 18,705.0 | $44.91 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2025-11-21 | Sale | 5,715.0 | $45.35 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2025-11-21 | Sale | 14,586.0 | $44.92 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2025-11-20 | Sale | 1,355.0 | $44.28 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2025-11-20 | Sale | 2,033.0 | $44.32 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2025-11-20 | Sale | 11,888.0 | $44.14 |
| Hoff Elizabeth A | Director | 2025-11-18 | Sale | 4,200.0 | $45.1 |
| Holloway Jean F | SVP, General Counsel | 2025-11-17 | Sale | 6,394.0 | $45.17 |
| Davis John E | Chief Commercial Officer | 2025-11-17 | Sale | 6,394.0 | $45.17 |
| Horton Amy | VP, Chief Accounting Officer | 2025-11-17 | Sale | 6,000.0 | $45.73 |
| Holloway Jean F | SVP, General Counsel | 2025-11-14 | Sale | 6,393.0 | $45.0 |
| Davis John E | Chief Commercial Officer | 2025-11-14 | Sale | 6,393.0 | $44.67 |
| Horton Amy | VP, Chief Accounting Officer | 2025-11-13 | Sale | 3,482.0 | $45.86 |
| Davis John E | Chief Commercial Officer | 2025-11-13 | Sale | 6,563.0 | $45.86 |
| Mackin James P | President & CEO | 2025-11-13 | Sale | 34,210.0 | $45.86 |
| Holloway Jean F | SVP, General Counsel | 2025-11-13 | Sale | 5,761.0 | $45.86 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2025-11-13 | Sale | 4,993.0 | $45.86 |
| Holloway Jean F | SVP, General Counsel | 2025-11-11 | Sale | 10,000.0 | $46.18 |
| Holloway Jean F | SVP, General Counsel | 2025-11-10 | Sale | 2,960.0 | $44.62 |
| Mackin James P | President & CEO | 2025-11-10 | Sale | 17,580.0 | $44.62 |
| Davis John E | Chief Commercial Officer | 2025-11-10 | Sale | 3,373.0 | $44.62 |
| Horton Amy | VP, Chief Accounting Officer | 2025-11-10 | Sale | 1,789.0 | $44.62 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2025-11-10 | Sale | 2,566.0 | $44.62 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2025-08-27 | Sale | 18,200.0 | $44.02 |
| Holloway Jean F | SVP, General Counsel | 2025-08-25 | Sale | 10,000.0 | $44.37 |
| Mackin James P | President & CEO | 2025-08-15 | Sale | 12,500.0 | $42.32 |
| Davis John E | Chief Commercial Officer | 2025-08-12 | Sale | 10,802.0 | $43.67 |
| Holloway Jean F | SVP, General Counsel | 2025-08-12 | Sale | 6,381.0 | $43.02 |
| Holloway Jean F | SVP, General Counsel | 2025-08-12 | Sale | 16,975.0 | $43.01 |
| Horton Amy | VP, Chief Accounting Officer | 2025-08-08 | Sale | 7,992.0 | $38.49 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2025-06-17 | Sale | 1,236.0 | $29.5 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2025-06-17 | Sale | 13,764.0 | $29.5 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2025-06-13 | Sale | 1,826.0 | $28.43 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2025-06-13 | Sale | 14,306.0 | $28.42 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2025-06-13 | Sale | 1,253.0 | $28.47 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2025-06-13 | Sale | 8,747.0 | $28.46 |
| Holloway Jean F | SVP, General Counsel | 2025-05-27 | Sale | 8,748.0 | $29.0 |
| SEMEDO ANTHONY B. | Director | 2025-05-23 | Sale | 2,600.0 | $28.47 |
| SEMEDO ANTHONY B. | Director | 2025-05-23 | Sale | 2,600.0 | $28.47 |
| Holloway Jean F | SVP, General Counsel | 2025-05-21 | Sale | 9,926.0 | $29.0 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2025-05-09 | Sale | 4,811.0 | $29.13 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2025-05-09 | Sale | 5,737.0 | $29.13 |
| Holloway Jean F | SVP, General Counsel | 2025-03-11 | Sale | 18,020.0 | $23.61 |
| Davis John E | Chief Commercial Officer | 2025-03-11 | Sale | 15,100.0 | $23.61 |
| Mackin James P | President & CEO | 2025-03-06 | Sale | 70,700.0 | $24.76 |
| Mackin James P | President & CEO | 2025-03-06 | Sale | 17,739.0 | $24.8 |
| Horton Amy | VP, Chief Accounting Officer | 2025-03-06 | Sale | 1,048.0 | $24.8 |
| Berry Lance A | Executive VP, CFO | 2025-03-06 | Sale | 4,909.0 | $24.8 |
| Davis John E | Chief Commercial Officer | 2025-03-06 | Sale | 2,618.0 | $24.8 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 2025-03-06 | Sale | 1,603.0 | $24.8 |
| Holloway Jean F | SVP, General Counsel | 2025-03-06 | Sale | 2,124.0 | $24.8 |
| Holloway Jean F | SVP, General Counsel | 2025-03-05 | Sale | 472.0 | $25.29 |
| SEMEDO ANTHONY B. | Director | 2025-03-05 | Purchase | 600.0 | $25.25 |
| SEMEDO ANTHONY B. | Director | 2025-03-05 | Purchase | 1,500.0 | $25.33 |
| Horton Amy | VP, Chief Accounting Officer | 2025-02-24 | Sale | 485.0 | $27.31 |
| Horton Amy | VP, Chief Accounting Officer | 2025-02-24 | Sale | 318.0 | $27.31 |
| Horton Amy | VP, Chief Accounting Officer | 2025-02-24 | Sale | 814.0 | $27.31 |
| Horton Amy | VP, Chief Accounting Officer | 2025-02-24 | Sale | 1,706.0 | $27.31 |
| Mackin James P | President & CEO | 2025-02-24 | Sale | 4,896.0 | $27.31 |
| Mackin James P | President & CEO | 2025-02-24 | Sale | 6,812.0 | $27.31 |
| Mackin James P | President & CEO | 2025-02-24 | Sale | 13,784.0 | $27.31 |
| Mackin James P | President & CEO | 2025-02-24 | Sale | 16,664.0 | $27.31 |